| Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma JH Rasmussen, G Lelkaitis, K Håkansson, IR Vogelius, HH Johannesen, ... British journal of cancer 120 (10), 1003-1006, 2019 | 147 | 2019 |
| Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis H Mehanna, M Taberna, C Von Buchwald, S Tous, J Brooks, M Mena, ... The Lancet Oncology 24 (3), 239-251, 2023 | 136 | 2023 |
| Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging MC Aznar, R Sersar, J Saabye, CN Ladefoged, FL Andersen, ... European journal of radiology 83 (7), 1177-1183, 2014 | 76 | 2014 |
| Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer JH Rasmussen, K Håkansson, IR Vogelius, MC Aznar, BM Fischer, ... Radiotherapy and Oncology 120 (1), 76-80, 2016 | 72 | 2016 |
| Feasibility of multiparametric imaging with PET/MR in head and neck squamous cell carcinoma JH Rasmussen, M Nørgaard, AE Hansen, IR Vogelius, MC Aznar, ... Journal of Nuclear Medicine 58 (1), 69-74, 2017 | 54 | 2017 |
| Pattern of and survival following loco-regional and distant recurrence in patients with HPV+ and HPV− oropharyngeal squamous cell carcinoma: A population-based study C Grønhøj, KK Jakobsen, DH Jensen, J Rasmussen, E Andersen, ... Oral oncology 83, 127-133, 2018 | 46 | 2018 |
| CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients J Rasmussen, K Aanæs, R Norling, KG Nielsen, HK Johansen, ... Journal of Cystic Fibrosis 11 (2), 93-99, 2012 | 46 | 2012 |
| Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma JH Rasmussen, C Grønhøj, K Håkansson, J Friborg, E Andersen, ... Annals of Oncology 30 (4), 629-636, 2019 | 42 | 2019 |
| Reproducibility of 18F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR JH Rasmussen, BM Fischer, MC Aznar, AE Hansen, IR Vogelius, ... The British journal of radiology 88 (1048), 20140655, 2015 | 37 | 2015 |
| Failure‐probability driven dose painting IR Vogelius, K Håkansson, AK Due, MC Aznar, AK Berthelsen, ... Medical Physics 40 (8), 081717, 2013 | 33 | 2013 |
| Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma GB Rasmussen, IR Vogelius, JH Rasmussen, L Schumaker, O Ioffe, ... Acta Oncologica 54 (9), 1408-1415, 2015 | 31 | 2015 |
| Dental artifacts in the head and neck region: implications for Dixon-based attenuation correction in PET/MR CN Ladefoged, AE Hansen, SH Keller, BM Fischer, JH Rasmussen, I Law, ... EJNMMI physics 2, 1-15, 2015 | 29 | 2015 |
| Prognostic value of 18F‐fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma JH Rasmussen, IR Vogelius, BM Fischer, J Friborg, MC Aznar, ... Head & Neck 37 (9), 1274-1281, 2015 | 26 | 2015 |
| Evaluation of long-term patient satisfaction and experience with the Baha® bone conduction implant J Rasmussen, SØ Olsen, LH Nielsen International journal of audiology 51 (3), 194-199, 2012 | 24 | 2012 |
| Feasibility of multiparametric positron emission tomography/magnetic resonance imaging as a one-stop shop for radiation therapy planning for patients with head and neck cancer AB Olin, AE Hansen, JH Rasmussen, CN Ladefoged, AK Berthelsen, ... International Journal of Radiation Oncology* Biology* Physics 108 (5), 1329-1338, 2020 | 22 | 2020 |
| Does multiparametric imaging with 18F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell … JH Rasmussen, A Olin, G Lelkaitis, AE Hansen, FL Andersen, ... British Journal of Cancer 123 (1), 46-53, 2020 | 22 | 2020 |
| Radiation dose-painting with protons vs. photons for head-and-neck cancer K Håkansson, B Smulders, L Specht, M Zhu, J Friborg, JH Rasmussen, ... Acta Oncologica 59 (5), 525-533, 2020 | 19 | 2020 |
| Prescribing and evaluating target dose in dose-painting treatment plans K Håkansson, L Specht, MC Aznar, JH Rasmussen, SM Bentzen, ... Acta oncologica 53 (9), 1251-1256, 2014 | 18 | 2014 |
| Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting JH Rasmussen, IR Vogelius, MC Aznar, BM Fischer, CB Christensen, ... Acta Oncologica 54 (9), 1416-1422, 2015 | 17 | 2015 |
| Robustness and generalizability of deep learning synthetic computed tomography for positron emission tomography/magnetic resonance imaging–based radiation therapy planning of … AB Olin, C Thomas, AE Hansen, JH Rasmussen, G Krokos, TG Urbano, ... Advances in radiation oncology 6 (6), 100762, 2021 | 15 | 2021 |
Ivan VogeliusClinical Professor at Dept. of Oncology, Rigshospitalet & Faculty of Health Sciences, CopenhagenVerificeret mail på regionh.dk
